D1-receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression

Molecular Brain Research

Volumn 53, Issue 1-2, 1998, Pages 69-77

  Crocker, S J ^a   Morelli, M ^b   Wigle, N ^a   Nakabeppu, Y ^c   Robertson, G S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Antisense oligonucleotide; Dopamine receptor; Immediate early gene; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ANTISENSE OLIGONUCLEOTIDE; APOMORPHINE; DOPAMINE 1 RECEPTOR; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, RAT; IMMEDIATE EARLY PROTEIN; OXIDOPAMINE; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MOTOR ACTIVITY; PHYSIOLOGY; STEREOTYPY; WISTAR RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; APOMORPHINE; CORPUS STRIATUM; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; IMMEDIATE-EARLY PROTEINS; MALE; MOTOR ACTIVITY; OLIGONUCLEOTIDES, ANTISENSE; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; STEREOTYPED BEHAVIOR; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0031602399     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00281-7     Document Type: Article

References (35)

1. Cenci M.A., Campbell K., Wictorin K., Björklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra. Eur. J. Neurosci. 4:1992;376-380.
2. Cohen D.R., Curran T. fra-1: a serum inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell Biol. 8:1988;2063-2069.
3. Curran T., Gordon M.B., Rubino K.L., Sambucetti L.C. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene. 2:1987;79-84.
4. Dobrzanski P., Noguchi T., Kovary K., Rizzo P., Lazo P.S., Bravo R. Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. Mol. Cell Biol. 11:1991;5470-5478.
5. Doucet J.-P., Nakabeppu Y., Benard P., Hope B.J., Nestler E.J., Jasmin B.J., Chen J.-S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of ΔFosB-like protein(s) in the striatum. Eur. J. Neurosci. 8:1996;365-381.
6. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
7. Guide for the Care and Use of Experimental Animals. Canadian Council of Animal Care, 151 Slater, Ottawa, Ontario, Canada K1P 4H3.
8. 1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell Biol. 11:1991;2451-2459.
9. Ljungberg T., Ungerstedt U. Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain. Exp. Neurol. 53:1976;585-600.
10. Marshall F.J., Richardson S., Teitelbaum P. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. J. Comp. Physiol. Psychol. 87:1974;808-830.
11. 2 receptors. Life Sci. 40:1987;245-251.
12. 2-dependent contraversive circling. Eur. J. Pharmacol. 141:1987;101-107.
13. Morelli M., Di Chiara G. Stereospecific blockade of N-methyl-D-aspartate transmission by MK-801 prevents priming of SKF 38393 induced turning. Psychopharmacology. 101:1990;287-288.
14. Morelli M., Fenu S., Garau L., Di Chiara G. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur. J. Pharmacol. 162:1989;329-335.
15. 2 receptors. Brain Res. 623:1993;334-336.
16. Morelli M., Fenu S., Pinna A., Cozzolino A., Carta A., Di Chiara G. 'Priming' to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the postsynaptic dopamine message. Behav. Pharmacol. 4:1993;389-397.
17. 1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen. Behav. Brain Res. 79:1996;93-100.
18. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
19. Mumberg D., Lucibello F.C., Schuermann M., Müller R. Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5:1991;1212-1223.
20. Nakabeppu Y., Nathans D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell. 64:1991;751-759.
21. Nakabeppu Y., Oda S., Sekiguchi M. Proliferative activation of quiescent Rat 1A cells by ΔFosB. Mol. Cell Biol. 13:1993;4157-4166.
22. Nishina H., Sato H., Suzuki T., Sato T., Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA. 87:1990;3619-3623.
23. 2-like dopamine receptors synergistically activates rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
24. 1 dopamine receptor behavioral response is dissociated from striatal immediate-early gene activity. Neuroscience. 66:1995;347-359.
25. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
26. Robertson G.S., Herrera D.G., Dragunow M., Robertson H.A. L-Dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur. J. Pharmacol. 159:1989;99-100.
27. 1-dopamine receptor agonists selectively activate c-fos independent of rotational behaviour. Brain Res. 503:1989;346-349.
28. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328.
29. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
30. Robertson G.S., Tetzlaff W., Bedard A., St-Jean M., Wigle N. c-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum. Neuroscience. 67:1995;325-344.
31. Shu S., Ju G., Fan L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85:1988;169-171.
32. Ungerstedt U., Arbuthnott G. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:1970;485-493.
33. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Phys. 367:1971;69-93.
34. Yen J., Wisdom R.M., Tratner I., Verma I.M. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc. Natl. Acad. Sci. USA. 88:1991;5077-5081.
35. Zerial M., Toschi L., Ryseck R.-P., Schuermann M., Müller R., Bravo R. The product of a novel growth factor activated gene, fosB interacts with Jun proteins enhancing their DNA binding activity. EMBO J. 8:1989;805-813.